| by Dr. Michael Murray
High Blood Pressure
What is behind the new guidelines for treatment of high blood pressure?
In case you missed it, last week new classifications of high blood
pressure and guidelines for treatment were released by the National
Heart, Lung, and Blood Institute (NHLBI). When I read the newspaper
accounts the changes seemed reasonable, but I was totally disgusted
when I read the actual article in JAMA the Journal of the American
Medical Association.1 Let me first explain the recommendations and
then explain why I am convinced the move is simply designed to put
more people on drugs.
For more than 3 decades the NHLBI has coordinated a coalition of
major professional organizations and federal agencies to increase
awareness, prevention, treatment, and control of high blood pressure.
The latest report, "The Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure" (JNC 7) was deemed necessary based the
publication of many new clinical trials since the sixth version
was released 6 years ago.
High blood pressure is a major risk factor for heart disease and
the chief risk factor for stroke and heart failure, and also can
lead to kidney damage. It affects about 50 million Americans - about
one in four adults and roughly half of the people over 65 years
old. With the new classification of "prehypertension"
level another 45 million persons are candidates for drug therapy
- but, there is a better way.
While I agree 100% with the rationale behind the new classification
and the importance of an optimal blood pressure below 120/80, what
I am totally against are the practical guidelines that overstress
the use of drugs rather than focus on diet, lifestyle, and appropriate
supplementation. Giving people drugs to lower blood pressure is
not the best first step at all. Diet, lifestyle modification, and
proper supplementation should be the first steps. If they are unsuccessful,
then drugs should definitely be used.
Essential hypertension is a ridiculous term
Most people with high blood pressure will be told by their physician
that they have "essential" hypertension. The term "essential"
is used to designate that the origin or cause of a particular disease
is unknown. Essentially, I think that the term essential hypertension
is utterly ridiculous. High blood pressure is clearly the result
of factors that lead to hardened, less compliant arteries or factors
that disrupt the kidneys ability to regulate fluid volume.
When the arteries become hard due to the build-up of plaque containing
cholesterol, blood pressure rises. Therefore, it is very important
to prevent atherosclerosis (hardening of the arteries). Just like
other degenerative diseases including atherosclerosis, the development
of high blood pressure is closely related to lifestyle and dietary
factors. Some of the important lifestyle factors which may cause
high blood pressure include stress, lack of exercise, and smoking.
Some of the dietary factors include: obesity; high sodium to potassium
ratio; low fiber, high sugar diet; high saturated fat and low omega-3
fatty acid intake; and a diet low in calcium, magnesium and vitamin
C. These same factors are known to also impact the ability of the
kidneys to regulate fluid volume and control blood pressure.
Diet in the treatment of hypertension
The "Dietary Approaches to Stop Hypertension" (DASH)
clinical studies were funded by the NHLBI to fully evaluate the
efficacy of a system of dietary recommendations in the treatment
of hypertension. The DASH diet is rich in fruits, vegetables, and
low fat dairy foods, and low in saturated and total fat. It also
is low in cholesterol, high in dietary fiber, potassium, calcium,
and magnesium, and moderately high in protein.
The first study showed that a diet rich in fruits, vegetables,
and low-fat dairy products can reduce blood pressure in the general
population and people with hypertension.2 The original DASH diet
did not require either sodium restriction or weight loss--the two
traditional dietary tools to control blood pressure--to be effective.3
The second study from the DASH research group found that coupling
the original DASH diet with sodium restriction is more effective
than either dietary manipulation alone.31 In the first trial, the
DASH diet produced a net blood pressure reduction of 11.4 and 5.5
mmHg systolic and diastolic, respectively, in patients with hypertension.
In the second trial, sodium intake was also quantified at a "higher"
intake of 3,300 milligrams per day; an "intermediate"
intake of 2,400 milligrams per day; and a "lower" intake
of 1,500 milligrams per day. Compared to the control diet, the DASH
diet was associated with a significantly lower systolic blood pressure
at each sodium level. The DASH diet with the lower sodium level
led to a mean systolic blood pressure that was 7.1 mmHg lower in
participants without hypertension, and 11.5 mmHg lower in participants
with hypertension. These results are clinically significant and
indicate that a sodium intake below the recommended level of 2,400
mg daily can significantly and quickly lower blood pressure.
Natural products to lower blood pressure
There is a new product that I hope will do as much good for people
with high blood pressure as glucosamine sulfate did for people with
osteoarthritis. The product is anti-ace peptides - a purified mixture
of 9 small peptides (proteins) derived from muscle of the fish bonito
(a member of the tuna family). I feature an article on this natural
product on my website. Basically, anti-ACE peptides works to lower
blood pressure by inhibiting ACE (angiotensin converting enzyme).
This enzyme converts angiotensin I to angiotensin II - a compound
that increases both the fluid volume and the degree of constriction
of the blood vessels. If we use a garden hose model illustrate the
pressure in your arteries, the formation of angiotensin II would
be similar to pinching off the hose while turning up the faucet
full blast. By inhibiting the formation of this compound, Anti-ACE
Peptides relax the arterial walls and reduce fluid volume. Anti-ACE
Peptides exert the strongest inhibition of ACE reported for any
naturally occurring substance available.
Three clinical studies have shown Anti-ACE Peptides exert significant
blood pressure lowering effects in people with high blood pressure
(hypertension).4-6 The material appears to be effective in about
two thirds of people with high blood pressure - about the same percentage
as many prescription drugs. (NOTE: People who do not respond to
Anti-ACE Peptides after a two month trial should try Celery Seed
Extract). The degree of blood pressure reduction in these studies
was quite significant, typically reducing the systolic by at least
10 mm Hg and the diastolic by 7 mm Hg in people with prehypertension
and Stage 1 hypertension. Greater reductions will be seen in people
with higher initial blood pressure readings.
Classification and Recommended Treatments For Stages of Hypertension
Blood Pressure Stages
(points) |
Group A (no
risk factors) |
Group B
(one or more risk factors†) |
Group C (certain
conditions††) |
Prehypertension
(120-139/80-89) |
Level 1 Support |
Level 1 Support |
Level 2 Support |
Stage 1 (140-159/90-99) |
Level 2 Support |
Level 2 Support |
Level 3 Support |
Stages 2 and 3 (>160/>100) |
Level 3 Support |
Level 3 Support |
Level 3 Support |
† Smoking, high cholesterol, age
over 60, or family history of heart disease
†† Diabetes, stroke, retinopathy, peripheral arterial
disease, nephropathy, or clinical signs of heart disease
Level 1 Support
- Foundational supplements (Natural Factors products)
- MultiStart multiple vitamin and mineral formula
- Enriching Greens - one serving daily
- RxOmega-3 Factors - 2 capsules daily
- Potassium chloride 1,500 to 3,000 mg (use NuSalt or NoSalt
salt substitutes to achieve dosage)
- Magnesium 150 to 400 mg three times daily
- ProMannan: 1,000 mg before meals three times daily
- Garlic: 4,000 mcg of allicin (I recommend Garlic Factors from
Natural Factors)
If after 2 months if there is no change add anti-ACE fish peptides:
1,500 mg daily. If after 2 months there is still no change,
discontinue anti-ACE fish peptides and replace with celery seed
extract: 150 mg daily.
Level 2 Support
- All of the above plus:
- Anti-ACE fish peptides: 1,500 mg daily
If after 2 months if there is no change add celery seed extract:
150 mg daily. If there is still no change, add Coenzyme Q10:
100 mg daily. If the blood pressure has not dropped below 140/105,
you will need to work with a physician to select the most appropriate
medication. If a prescription drug is necessary, a diuretic
alone is often the first recommendation
Level 3 Support
Consult a physician immediately. A drug may be necessary to achieve
initial control calcium channel blockers or ACE inhibitors alone
or in combination with a diuretic appear to be the safest when
Level 3 Support is required. Follow the supplement recommendations
given for Level 2 Support. When satisfactory control over the
high blood pressure has been achieved, work with the physician
to taper off the medication.
Key References:
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report
of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. The JNC 7 Report. see http://jama.ama-assn.org/cgi/content/full/289.19.2560v12560.
- Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of
the effects of dietary patterns on blood pressure. DASH Collaborative
Research Group. N Engl J Med 1997; 336:1117-24.
- Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches
to Stop Hypertension) diet is effective treatment for stage 1
isolated systolic hypertension. Hypertension 2001; 38:155-8.
- Fujita H, Yamagami T, Ohshima K. Effect of an ace-inhibitory
agent, katuobishi oligopeptide, in the spontaneously hypertensive
rat and in borderline and mildly hypertensive subjects. Nutr Res
2001;21:1149-58.
- Fujita H, Yasumoto R, Hasegawa M, Ohshima K. Antihypertensive
activity of "Katsuobushi Oligopeptide" in hypertensive
and borderline hypertensive subjects. Jpn Pharmacol Ther 1997;25:147-51.
- Fujita H, Yasumoto R, Hasegawa M, Ohshima K. Antihypertensive
activity of "Katsuobushi Oligopeptide" in hypertensive
and borderline hypertensive subjects. Jpn Pharmacol Ther 1997;25:153-7.
|